Bovine Erythropoietic Protoporphyria (BEPP)
This is an hereditary defect, recorded in both cattle and man, resulting from a deficiency of ferrochelatase -the terminal enzyme catalyzing the insertion of ferrous ion into protoporphyrin IX to form haem.
Deficiency results in elevated concentrations of protoporphyrin in erythrocytes and tissues and inadequate production of haemoglobin. Protoporphyrin is a photodynamic agent and BEPP is characterised by signs of photosensitisation.
In man it is thought to be associated with an autosomal dominant gene with variable penetrance whereas in cattle an autosomal recessive gene is thought to be involved.
Limousin is the main breed affected although it has been reported in Blonde d'Aquitaine
Occurrence
First reported in the USA in 1977 . Reported in France (1991 and Australia (1992) .
The condition had rarely been reported in the United Kingdom before 2007. However, following the diagnosis of BEPP in a Limousin calf in the summer of 2007 at Veterinary Laboratories Agency (VLA) Penrith Regional Laboratory, many more cases have come to light, in both England and Wales. 2. Photosensitisation secondary to severe liver damage resulting in excess levels of the photodynamic agent phylloerythrin (formed from chlorophyll).
Signs
3. Malignant catarrhal fever.
4. Bluetongue (BTV-8).
5. Bovine congenital porphyria -see discoloured (pink) teeth, anaemia and porphyrin in urine. Pigments fluoresce in UV light. Signs present at birth.
• Simple recessive inheritance affecting many breeds including Shorthorn, Ayrshire, Friesian.
Genetic testing
The North American Limousin Foundation (NALF), Canadian Limousin Foundation and Australian Limousin Breeders Association all have PCR-based testing methods. This relies on amplification of the mutant ferrochelatase gene. In North America, for progeny to be eligible for the NALF herdbook, AI sires must have a genotype for protoporphyria ("proto") on file. There is no equivalent testing programme in the United Kingdom.
Conclusion
The incidence of this condition in the UK is unknown. Initiation of a scheme by the The British Limousin Cattle Society, along the lines of those adopted in other countries, would provide useful data on the true incidence of this condition, and may ultimately prove essential.
Recent experience within the Veterinary Laboratories Agency would suggest that the condition is more common than previously suspected. Even without the adoption of a national scheme it is hoped that increased practitioner familiarity with the condition will result in a more accurate estimation of its prevalence in the United Kingdom. 
